Abiopharma

🔍 Canter Shawn (Director)

Company: KULR Technology Group, Inc. (KULR)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 19,369 shares of Common Stock at $2.17 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 326,978.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents the number of shares of Common Stock that were withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the net settlement of restricted stock units ("RSUs") previously granted under the Issuer's equity incentive plan and does not represent a sale.
• F2: Represents the previous closing price of the Issuer's Common Stock on the vesting date and does not represent a sale.